Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection
Heiko Pietsch1, Felicitas Escher1, Ganna Aleshcheva2
1Institute for Cardiac Diagnostics and Therapy, IKDT GmbH, Berlin, Germany; Charité - University Medicine Berlin, Department of Cardiology, CVK, Berlin, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
Abstract:
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has reached pandemic levels. Cardiovascular complications in COVID-19 have been reported frequently, however evidence for a causal relationship has not been established. This report describes the detection of SARS-CoV-2 viral genomes in a patient with symptoms of heart failure, in whom endomyocardial biopsy was investigated following a latency period of 4 weeks after the onset of pulmonary symptoms. The viral infection was accompanied by myocardial inflammation indicating an infection of the heart muscle.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies


